Allergology International · 2008 · 14 citations · 10 references
Our data show that all BGP-allergic patients simultaneously exhibit higher IgE antibody levels to recombinant and natural P. pratense allergens as well as to crude TGP extract. This suggests that when choosing an immunotherapeutic regimen for BGP-sensitised patients (after establishing their IgE profile via purified TGP-allergens), subcutaneous or sublingual TGP-extract vaccines in appropriate doses, in order to influence T epitope specificity, might be beneficial. Though extremely uncommon, in cases where a patient is exclusively BGP allergen-sensitised, BGP-extract therapy is the appropriate therapeutic response.
10
Beatrice Jahn‐Schmid, Astrid Radakovics, D. Lüttkopf et al. · Journal of Allergy and Clinical Immunology · 2005 · 161 citations
The association fo age, gender and smoking with total IgE and specific IgE
Deborah Jarvis, Christina Luczynska, S Chinn et al. · Clinical & Experimental Allergy · 1995 · 102 citations